Skip to main content
Journal cover image

Corrigendum: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin (Clinical Pharmacology Therapeutics (2008) 84, (326-331) DOI: 10.1038/clpt.2008.10)

Publication ,  Journal Article
Gage, BF; Eby, C; Johnson, JA; Deych, E; Rieder, MJ; Ridker, PM; Milligan, PE; Grice, G; Lenzini, P; Rettie, AE; Aquilante, CL; Grosso, L ...
Published in: Clinical Pharmacology and Therapeutics
September 1, 2008

Duke Scholars

Published In

Clinical Pharmacology and Therapeutics

DOI

EISSN

1532-6535

ISSN

0009-9236

Publication Date

September 1, 2008

Volume

84

Issue

3

Start / End Page

430

Related Subject Headings

  • Pharmacology & Pharmacy
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gage, B. F., Eby, C., Johnson, J. A., Deych, E., Rieder, M. J., Ridker, P. M., … McLeod, H. L. (2008). Corrigendum: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin (Clinical Pharmacology Therapeutics (2008) 84, (326-331) DOI: 10.1038/clpt.2008.10). Clinical Pharmacology and Therapeutics, 84(3), 430. https://doi.org/10.1038/clpt.2008.112
Gage, B. F., C. Eby, J. A. Johnson, E. Deych, M. J. Rieder, P. M. Ridker, P. E. Milligan, et al. “Corrigendum: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin (Clinical Pharmacology Therapeutics (2008) 84, (326-331) DOI: 10.1038/clpt.2008.10).” Clinical Pharmacology and Therapeutics 84, no. 3 (September 1, 2008): 430. https://doi.org/10.1038/clpt.2008.112.
Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, et al. Corrigendum: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin (Clinical Pharmacology Therapeutics (2008) 84, (326-331) DOI: 10.1038/clpt.2008.10). Clinical Pharmacology and Therapeutics. 2008 Sep 1;84(3):430.
Gage, B. F., et al. “Corrigendum: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin (Clinical Pharmacology Therapeutics (2008) 84, (326-331) DOI: 10.1038/clpt.2008.10).” Clinical Pharmacology and Therapeutics, vol. 84, no. 3, Sept. 2008, p. 430. Scopus, doi:10.1038/clpt.2008.112.
Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL. Corrigendum: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin (Clinical Pharmacology Therapeutics (2008) 84, (326-331) DOI: 10.1038/clpt.2008.10). Clinical Pharmacology and Therapeutics. 2008 Sep 1;84(3):430.
Journal cover image

Published In

Clinical Pharmacology and Therapeutics

DOI

EISSN

1532-6535

ISSN

0009-9236

Publication Date

September 1, 2008

Volume

84

Issue

3

Start / End Page

430

Related Subject Headings

  • Pharmacology & Pharmacy
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences